相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improved bone and renal safety of switching from tenofovir disoproxil fumarate to tenofovir alafenamide: preliminary results from 2 phase 3 studies in HBeAg-positive and HBeAg-negative patients with chronic hepatitis B
H. L. Chan et al.
JOURNAL OF HEPATOLOGY (2017)
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting
Laura Milazzo et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients
P. Lampertico et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Henry L. Y. Chan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Maria Buti et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
W. Ray Kim et al.
CANCER (2015)
Effect of Nucleoside and Nucleotide Analogues on Renal Function in Patients With Chronic Hepatitis B Virus Monoinfection
Vincent Mallet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Tenofovir-Related Nephropathies in HIV-Infected Patients
Silvia Lai et al.
CURRENT VASCULAR PHARMACOLOGY (2015)
Diabetes and chronic kidney disease
Andrew Kowalski et al.
DM DISEASE-A-MONTH (2015)
Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B
S. Koklu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria
Motonobu Nishimura et al.
HYPERTENSION RESEARCH (2013)
Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Robert G. Gish et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir
Alana Brennan et al.
AIDS (2011)
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Stefan Mauss et al.
JOURNAL OF HEPATOLOGY (2011)
Association of standardized estimated glomerular filtration rate with the prevalence of hypertension among adults in the United States
X. Liu et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients
Ryan D. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2010)
To GEE or Not to GEE Comparing Population Average and Mixed Models for Estimating the Associations Between Neighborhood Risk Factors and Health
Alan E. Hubbard et al.
EPIDEMIOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Etiology and clinical characteristics of membranous nephropathy in Chinese patients
Cai-Hong Zeng et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Viral infections and the kidney: HIV, hepatitis B, and hepatitis C
Gerald Appel
CLEVELAND CLINIC JOURNAL OF MEDICINE (2007)
Tenofovir-related nephrotoxicity in HIV-infected patients
A Barrios et al.
AIDS (2004)
分享论文
